The company's product, ContraBand, is an innovative catheter-delivered implant that treats left ventricle failure, improves LV ejection fraction, reduces mitral regurgitation, and restores favorable ventricular geometry. Founded in 2016 and headquartered in Or Yehuda, Israel, Restore Medical aims to provide a unique solution for patients with congestive heart failure, which remains one of the leading causes of death and hospitalization worldwide. Their mission is to improve CHF patients' quality of life and reduce hospital readmission rates with ContraBand.